| MirGeneDB 2.0: the metazoan microRNA complement B Fromm, D Domanska, E Høye, V Ovchinnikov, W Kang, ... Nucleic Acids Research 48 (D1), D132-D141, 2020 | 237 | 2020 |
| MirGeneDB 2.1: toward a complete sampling of all major animal phyla B Fromm, E Høye, D Domanska, X Zhong, E Aparicio-Puerta, ... Nucleic acids research 50 (D1), D204-D210, 2022 | 98 | 2022 |
| On the presence and immunoregulatory functions of extracellular microRNAs in the trematode Fasciola hepatica B Fromm, V Ovchinnikov, E Høye, D Bernal, M Hackenberg, A Marcilla Parasite immunology 39 (2), e12399, 2017 | 58 | 2017 |
| Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases VJ Dagenborg, SE Marshall, S Yaqub, K Grzyb, K Boye, M Lund-Iversen, ... Cancer Biology & Therapy 21 (5), 432-440, 2020 | 27 | 2020 |
| microRNAs as cancer biomarkers K Flatmark, E Høye, B Fromm Scandinavian Journal of Clinical and Laboratory Investigation 76 (sup245 …, 2016 | 26 | 2016 |
| MapToCleave: High-throughput profiling of microRNA biogenesis in living cells W Kang, B Fromm, AJ Houben, E Høye, D Bezdan, C Arnan, K Thrane, ... Cell reports 37 (7), 2021 | 22 | 2021 |
| A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer E Høye, B Fromm, PHM Böttger, D Domanska, A Torgunrud, ... NAR cancer 4 (1), zcab051, 2022 | 12* | 2022 |
| Insights into early animal evolution form the genome of the xenacoelomorph worm Xenoturbella bocki PH Schiffer, P Natsidis, DJ Leite, HE Robertson, F Lapraz, F Marlétaz, ... Elife 13, e94948, 2024 | 10* | 2024 |
| T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases E Høye, VJ Dagenborg, A Torgunrud, C Lund-Andersen, ÅA Fretland, ... GigaScience 12, giad032, 2023 | 2 | 2023 |
| Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade AH Ree, E Høye, Y Esbensen, ACR Beitnes, A Negård, L Bernklev, ... Oncoimmunology 13 (1), 2372886, 2024 | | 2024 |
| 543P Tumor mutational burden (TMB), BRAF status, and C-reactive protein (CRP) predict response to first-line alternating oxaliplatin-based chemotherapy and nivolumab in … AH Ree, PA Bousquet, HL Nilsen, T Lüders, S Wang, T Visnovska, ... Annals of Oncology 35, S453, 2024 | | 2024 |
| Predictive value of tumor mutational burden (TMB) in patients with metastatic microsatellite-stable (MSS) colorectal cancer (CRC) given first-line oxaliplatin-based … AH Ree, PA Bousquet, HL Nilsen, T Lüders, S Wang, T Visnovska, ... Cancer Research 84 (6_Supplement), 2522-2522, 2024 | | 2024 |
| Computational approaches in colorectal cancer metastasis E Høye | | 2023 |
| A microRNA Signature of Metastatic Colorectal Cancer E Høye, B Fromm, PHM Böttger, D Domanska, A Torgunrud, ... | | 2020 |
| MicroRNAs in Metastasis E Høye | | 2016 |
| Posts navigation B Fromm, E Høye, D Domanska, X Zhong, E Aparicio-Puerta, ... | | |
